121 related articles for article (PubMed ID: 29292491)
1. Long-Term Systematic Monitoring of Four Polish Transaldolase Deficient Patients.
Lipiński P; Pawłowska J; Stradomska T; Ciara E; Jankowska I; Socha P; Tylki-Szymańska A
JIMD Rep; 2018; 42():79-87. PubMed ID: 29292491
[TBL] [Abstract][Full Text] [Related]
2. Successful Liver Transplantation in Two Polish Brothers with Transaldolase Deficiency.
Stefanowicz M; Janowska M; Pawłowska J; Tylki-Szymańska A; Kowalski A; Szymczak M; Kaliciński P; Jankowska I
Children (Basel); 2021 Aug; 8(9):. PubMed ID: 34572178
[TBL] [Abstract][Full Text] [Related]
3. Untargeted metabolomics as an unbiased approach to the diagnosis of inborn errors of metabolism of the non-oxidative branch of the pentose phosphate pathway.
Shayota BJ; Donti TR; Xiao J; Gijavanekar C; Kennedy AD; Hubert L; Rodan L; Vanderpluym C; Nowak C; Bjornsson HT; Ganetzky R; Berry GT; Pappan KL; Sutton VR; Sun Q; Elsea SH
Mol Genet Metab; 2020; 131(1-2):147-154. PubMed ID: 32828637
[TBL] [Abstract][Full Text] [Related]
4. Clinical and molecular characteristics of two transaldolase-deficient patients.
Tylki-Szymanska A; Wamelink MM; Stradomska TJ; Salomons GS; Taybert J; Dąbrowska-Leonik N; Rurarz M
Eur J Pediatr; 2014 Dec; 173(12):1679-82. PubMed ID: 24497183
[TBL] [Abstract][Full Text] [Related]
5. Transaldolase deficiency in a two-year-old boy with cirrhosis.
Wamelink MM; Struys EA; Salomons GS; Fowler D; Jakobs C; Clayton PT
Mol Genet Metab; 2008 Jun; 94(2):255-8. PubMed ID: 18331807
[TBL] [Abstract][Full Text] [Related]
6. Transaldolase deficiency in two new patients with a relative mild phenotype.
Tylki-Szymańska A; Stradomska TJ; Wamelink MM; Salomons GS; Taybert J; Pawłowska J; Jakobs C
Mol Genet Metab; 2009 May; 97(1):15-7. PubMed ID: 19299175
[TBL] [Abstract][Full Text] [Related]
7. Hypergonadotrophic hypogonadism in a patient with transaldolase deficiency: novel mutation in the pentose phosphate pathway.
Lafcı NG; Colak FK; Sahin G; Sakar M; Çetinkaya S; Savas-Erdeve S
Hormones (Athens); 2021 Sep; 20(3):581-585. PubMed ID: 33159679
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial involvement and erythronic acid as a novel biomarker in transaldolase deficiency.
Engelke UF; Zijlstra FS; Mochel F; Valayannopoulos V; Rabier D; Kluijtmans LA; Perl A; Verhoeven-Duif NM; de Lonlay P; Wamelink MM; Jakobs C; Morava E; Wevers RA
Biochim Biophys Acta; 2010 Nov; 1802(11):1028-35. PubMed ID: 20600873
[TBL] [Abstract][Full Text] [Related]
9. Clinical, biochemical, and molecular overview of transaldolase deficiency and evaluation of the endocrine function: Update of 34 patients.
Williams M; Valayannopoulos V; Altassan R; Chung WK; Heijboer AC; Keng WT; Lapatto R; McClean P; Mulder MF; Tylki-Szymańska A; Walenkamp ME; Alfadhel M; Alakeel H; Salomons GS; Eyaid W; Wamelink MMC
J Inherit Metab Dis; 2019 Jan; 42(1):147-158. PubMed ID: 30740741
[TBL] [Abstract][Full Text] [Related]
10. Nephrological abnormalities in patients with transaldolase deficiency.
Loeffen YG; Biebuyck N; Wamelink MM; Jakobs C; Mulder MF; Tylki-Szymańska A; Fung CW; Valayannopoulos V; Bökenkamp A
Nephrol Dial Transplant; 2012 Aug; 27(8):3224-7. PubMed ID: 22510381
[TBL] [Abstract][Full Text] [Related]
11. Identification of transaldolase as a novel serum biomarker for hepatocellular carcinoma metastasis using xenografted mouse model and clinic samples.
Wang C; Guo K; Gao D; Kang X; Jiang K; Li Y; Sun L; Zhang S; Sun C; Liu X; Wu W; Yang P; Liu Y
Cancer Lett; 2011 Dec; 313(2):154-66. PubMed ID: 22023829
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary manifestations in a patient with transaldolase deficiency.
Jassim N; Alghaihab M; Saleh SA; Alfadhel M; Wamelink MM; Eyaid W
JIMD Rep; 2014; 12():47-50. PubMed ID: 23846909
[TBL] [Abstract][Full Text] [Related]
13. [Transaldolase deficiency - clinical outcome, pathogenesis, diagnostic process].
Lipiński P; Stradomska T; Tylki-Szymańska A
Dev Period Med; 2018; 22(2):187-196. PubMed ID: 30056406
[TBL] [Abstract][Full Text] [Related]
14. Transaldolase deficiency: report of 12 new cases and further delineation of the phenotype.
Eyaid W; Al Harbi T; Anazi S; Wamelink MM; Jakobs C; Al Salammah M; Al Balwi M; Alfadhel M; Alkuraya FS
J Inherit Metab Dis; 2013 Nov; 36(6):997-1004. PubMed ID: 23315216
[TBL] [Abstract][Full Text] [Related]
15. N-Acetylcysteine Therapy in an Infant with Transaldolase Deficiency Is Well Tolerated and Associated with Normalization of Alpha Fetoprotein Levels.
Rodan LH; Berry GT
JIMD Rep; 2017; 31():73-77. PubMed ID: 27130472
[TBL] [Abstract][Full Text] [Related]
16. Apparent Acetaminophen Toxicity in a Patient with Transaldolase Deficiency.
Lee-Barber J; English TE; Britton JF; Sobreira N; Goldstein J; Valle D; Bjornsson HT
JIMD Rep; 2019; 44():9-15. PubMed ID: 29923087
[TBL] [Abstract][Full Text] [Related]
17. Transaldolase deficiency: liver cirrhosis associated with a new inborn error in the pentose phosphate pathway.
Verhoeven NM; Huck JH; Roos B; Struys EA; Salomons GS; Douwes AC; van der Knaap MS; Jakobs C
Am J Hum Genet; 2001 May; 68(5):1086-92. PubMed ID: 11283793
[TBL] [Abstract][Full Text] [Related]
18. Ribose-5-phosphate isomerase deficiency: new inborn error in the pentose phosphate pathway associated with a slowly progressive leukoencephalopathy.
Huck JH; Verhoeven NM; Struys EA; Salomons GS; Jakobs C; van der Knaap MS
Am J Hum Genet; 2004 Apr; 74(4):745-51. PubMed ID: 14988808
[TBL] [Abstract][Full Text] [Related]
19. Transaldolase deficiency: a new cause of hydrops fetalis and neonatal multi-organ disease.
Valayannopoulos V; Verhoeven NM; Mention K; Salomons GS; Sommelet D; Gonzales M; Touati G; de Lonlay P; Jakobs C; Saudubray JM
J Pediatr; 2006 Nov; 149(5):713-7. PubMed ID: 17095351
[TBL] [Abstract][Full Text] [Related]
20. Transaldolase Deficiency: A New Case Expands the Phenotypic Spectrum.
Banne E; Meiner V; Shaag A; Katz-Brull R; Gamliel A; Korman S; Cederboim SH; Duvdevani MP; Frumkin A; Zilkha A; Kapuller V; Arbell D; Cohen E; Eventov-Friedman S
JIMD Rep; 2016; 26():31-6. PubMed ID: 26238251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]